Scott Gottlieb explains the folly of this:
When it comes to trying to manage drug risks and encourage safe prescribing, the FDA has plenty of reason to worry about how drugs get used. Many practitioners have a hard time explaining remote risks to their patients, and many patients a harder time understanding them. But the FDA can’t rationalize the diversity of peoples’ medical decision-making or the fact that some doctors, and patients, will simply choose to reject the agency’s medical practice advice or its computations when benefits justify certain risks.Nor will any amount of regulation on how medicines are used defuse the risk that comes from medical care, or the uncertainty that inevitably lingers around new treatments. When it comes to medical practice, the agency’s job isn’t to find reasons to keep effective drugs from patients by actively managing prescribing decisions, but to surface obtainable information about risks and benefits so that patients can make informed choices for themselves.
Related posts:
- Simpd: The Society For Innovative Practice Design
- Should you choose internal medicine or family practice?
- ACP: A practice model for increasing the appeal of General Internal Medicine
- Should general internal medicine merge with family practice?
- Defensive medicine op-ed reaction
- Why do doctors practice defensive medicine?
- Relative value units, and how the RVU payment system doesn’t allow doctors to practice good medicine
 
Follow on Twitter  
Subscribe








{ 1 comment }
The American society has lost absolutely all love and respect for freedom. Medicine, like everything else, is becoming regimented within the strict boundaries of, what for the moment at least, is considered “the right way”–never mind that “the right way” is an ever moving “standard” and often it is those punished for daring to live by their own lights who end up being closer to the truth when enough evidence finally comes in.
Comments on this entry are closed.